| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |